Champions Oncology Inc Stock
?
Your prediction
Champions Oncology Inc Stock
Pros and Cons of Champions Oncology Inc in the next few years
Pros
Cons
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | 1.690% | -2.869% | -4.819% | -15.357% | -18.276% | -2.469% | -40.750% |
| Heron Therapeutics Inc. | 7.600% | -50.806% | -66.818% | -80.098% | -67.145% | -65.143% | -96.715% |
| Evolus Inc | -2.000% | 2.559% | 6.592% | -31.006% | 4.440% | -29.292% | -36.402% |
| Rhythm Pharmaceuticals | -1.330% | -1.316% | -8.537% | 31.579% | -19.786% | 374.684% | 393.421% |
News
KinderCare Learning Companies Q1 Earnings Call Highlights
KinderCare Learning Companies (NYSE:KLC) reported modest first-quarter revenue growth while management said lower enrollment in its early childhood education centers continued to pressure
U.S. Polo Assn. Supports Division I National Intercollegiate Championship, Showcasing the Future of the Sport of Polo
DI Women's and Men's Finals to be Featured in ‘Breakaway: Polo in College' on ESPN
WEST PALM BEACH, FLA. / ACCESS Newswire / April 2, 2026 / U.S. Polo Assn., the official sports brand of
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D
HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology,

